This week, Johnson & Johnson etched its name in the history books of another big pharma company that has been fined over billions of dollars due to a drug manufacturer practices of improper marketing and failure to warn. Johnson & Johnson pled guilty to...
DePuy Hip Replacement
United Kingdom Seeks to Eliminate the Use of Metal-on-Metal Implants Due to High Failure Rate
Because of the high failure rates of metal on metal hip devices, and the potential for toxic exposure, the United Kingdom is moving to ban all metal-on-metal hip replacements performed at National Health Service [NHS] hospitals. NHS is the publicly funded health care...
DePuy September 23, 2013 Bellwether Trial Continued
On September 20, the Honorable David Katz presiding over the DePuy bellwether case, Ann McCracken v. DePuy Orthopaedics, Inc., et. al., Case No. 11 dp 20485, continued the trial 90 days from September 24, 2013 “in the interest of justice”. According to the Order, the...
Johnson & Johnson Recalls Another DePuy Orthopedic Product
Johnson & Johnson (J&J) is no stranger to controversy. From being embroiled in massive litigation in DePuy ASR artificial hips, Pinnacle litigation, and in the transvaginal mesh litigation with its Ethicon Gynecare products to its multiple legal troubles and...
510(k); Pathway for Safer drugs or Recipe for Disaster
Recent medical disasters such as the DePuy ASR, DePuy Pinnacle, and transvaginal mesh cases have revealed that medical devices were approved for use without adequate clinical data based on a grandfathering type provision in the FDA called a 510(k) process, where a new...
Are Too Many Doctors Simply Sales People for Big Pharma?
Big Pharma paid doctors more than $1 billion in 2012 to act in various spokesperson capacities, for travel and meals, as well as research and royalties, which is significantly more than reported in 2011. According to a new data reported in the Financial Times, that...
Who is Responsible for J&J’s DePuy ASR, Pinnacle, Ethicon’s Gynecare, and Merck’s Vioxx and Fosamax?
Consumers injured by defective devices face an armada of attorneys as they seek to hold accountable device makers such as J&J’s hip implants DePuy ASR, DePuy Pinnacle, J&J’s transvaginal mesh product Ethicon, and Merck’s FOSAMAX that has left countless post...
J&J’s DePuy Unit Abandons Pinnacle and All Metal Hip Implants
On May 16, 2013, in what many health advocates feel is a long overdue move, J&J’s DePuy Orthopedic unit announced it was stopping the manufacture of all metal replacement hips. In August 2010 the unit recalled the DePuy ASR in the face of mounting evidence of...
Risperdal adds to DePuy and Ethicon Troubles for J&J
Johnson and Johnson (J&J), already embroiled in massive litigation in DePuy ASR artificial hips, and in the trans vaginal mesh litigation from its Ethicon Gynecare products, faces another significant issue over its mounting legal troubles stemming from its...
Medical Device Reporting for People Injured by Vaginal Mesh, Actos, Fosamax, and DePuy ASRs: What the Consumer Needs to Know
Manufacturers, user facilities and importers of medical devices are mandated to submit certain adverse events to the U.S. Food and Drug Administration [FDA]. Medical device reporting requires that manufacturers report to the FDA when they learn that one of their...